Capital Asset Advisory Services’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,443
| Closed | -$549K | – | 604 |
|
|
2021
Q3 | $549K | Sell |
3,443
-55
| -2% | -$8.77K | 0.06% | 240 |
|
|
2021
Q2 | $460K | Buy |
3,498
+152
| +5% | +$20K | 0.05% | 277 |
|
|
2021
Q1 | $431K | Buy |
3,346
+794
| +31% | +$102K | 0.06% | 278 |
|
|
2020
Q4 | $426K | Buy |
2,552
+775
| +44% | +$129K | 0.08% | 227 |
|
|
2020
Q3 | $274K | Sell |
1,777
-12
| -0.7% | -$1.85K | 0.06% | 252 |
|
|
2020
Q2 | $251K | Buy |
1,789
+240
| +15% | +$33.7K | 0.05% | 289 |
|
|
2020
Q1 | $208K | Buy |
+1,549
| New | +$208K | 0.06% | 276 |
|